Colgate-Palmolive (NYSE:CL) Price Target Raised to $87.00

Colgate-Palmolive (NYSE:CL - Get Free Report) had its target price increased by equities researchers at Barclays from $86.00 to $87.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm presently has an "equal weight" rating on the stock. Barclays's target price suggests a potential upside of 0.14% from the company's current price.

A number of other research firms have also recently weighed in on CL. Piper Sandler cut their price target on Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating on the stock in a research note on Monday, March 31st. JPMorgan Chase & Co. raised their price target on Colgate-Palmolive from $95.00 to $103.00 and gave the company an "overweight" rating in a research note on Monday, April 28th. Citigroup raised their price target on Colgate-Palmolive from $103.00 to $108.00 and gave the company a "buy" rating in a research note on Monday, April 28th. UBS Group raised their price objective on Colgate-Palmolive from $105.00 to $109.00 and gave the stock a "buy" rating in a report on Thursday, April 17th. Finally, Wells Fargo & Company raised their price objective on Colgate-Palmolive from $83.00 to $88.00 and gave the stock an "underweight" rating in a report on Wednesday, April 2nd. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and eight have given a buy rating to the company's stock. Based on data from MarketBeat, Colgate-Palmolive currently has a consensus rating of "Hold" and a consensus price target of $101.00.

Colgate-Palmolive Trading Up 0.2%

NYSE:CL traded up $0.16 during trading hours on Tuesday, reaching $86.88. 4,959,544 shares of the stock were exchanged, compared to its average volume of 5,287,353. The company has a quick ratio of 0.54, a current ratio of 0.85 and a debt-to-equity ratio of 8.96. The business has a 50-day moving average of $90.40 and a two-hundred day moving average of $90.41. Colgate-Palmolive has a twelve month low of $85.32 and a twelve month high of $109.30. The company has a market capitalization of $70.41 billion, a price-to-earnings ratio of 24.54, a PEG ratio of 4.63 and a beta of 0.37.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings data on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.86 by $0.05. The business had revenue of $4.91 billion for the quarter, compared to analysts' expectations of $4.92 billion. Colgate-Palmolive had a return on equity of 461.04% and a net margin of 14.52%. The company's revenue for the quarter was down 3.0% compared to the same quarter last year. During the same period last year, the firm earned $0.86 earnings per share. On average, equities analysts predict that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive announced that its Board of Directors has authorized a share buyback plan on Thursday, March 20th that allows the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization allows the company to reacquire up to 6.8% of its shares through open market purchases. Shares repurchase plans are often a sign that the company's management believes its shares are undervalued.

Institutional Investors Weigh In On Colgate-Palmolive

A number of institutional investors have recently added to or reduced their stakes in CL. Brighton Jones LLC boosted its holdings in Colgate-Palmolive by 4.4% in the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company's stock valued at $962,000 after purchasing an additional 450 shares in the last quarter. Bernard Wealth Management Corp. acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth approximately $36,000. Proficio Capital Partners LLC acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth approximately $186,000. Flagship Wealth Advisors LLC purchased a new stake in Colgate-Palmolive in the 4th quarter worth approximately $100,000. Finally, Axxcess Wealth Management LLC grew its stake in Colgate-Palmolive by 0.3% in the 4th quarter. Axxcess Wealth Management LLC now owns 38,786 shares of the company's stock worth $3,526,000 after acquiring an additional 117 shares during the period. Hedge funds and other institutional investors own 80.41% of the company's stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.